SearchResearch productsPartner with us中文
English
Light R&D pipeline banner featuring a luminous migrasome network

R&D PIPELINE

R&D PIPELINE

Bringing original biological discoveries from China to patients worldwide

View the public pipelineExplore the technology platform

PIPELINE OVERVIEW

Across delivery and diagnostics, the pipeline maps programmes from proof of concept through candidate selection, registration and clinical translation.

12Active programmes
0705Two product tracks

ENGINEERED MIGRASOME DELIVERY

Engineered migrasome delivery

7 PROGRAMS IN DEVELOPMENTPIPELINE OVERVIEW / R&D PROGRESS

Using engineered migrasomes as carriers, this track explores precise intercellular delivery of nucleic acids, proteins and gene-editing tools.

Engineered migrasome delivery platform pipeline

ProgramsPROGRAMS
01Proof of concept概念验证02Candidate selected候选药物确定03CMC preparationCMC 准备04pre-INDIND 准备05Clinical trials and submission临床试验及申报
  1. MGS-mRNA-001mRNA and protein deliveryRDEB (skin)
  2. MGS-mRNA-002mRNA and protein deliveryAesthetics
  3. MGS-GT-001Gene-editing-system deliveryDM1 (muscle)
  4. MGS-MT-001Mitochondrial deliveryLHON (eye)
  5. MGS-MT-002Mitochondrial deliveryAMI (heart)
  6. MGS-MT-003Mitochondrial deliveryAnti-aging
  7. MGS-ON-001Complex drug-type deliveryOncology
  1. MGS-mRNA-001mRNA and protein delivery

    RDEB (skin)

    Current public stageCMC preparation
  2. MGS-mRNA-002mRNA and protein delivery

    Aesthetics

    Current public stageProof of concept
  3. MGS-GT-001Gene-editing-system delivery

    DM1 (muscle)

    Current public stageCandidate selected
  4. MGS-MT-001Mitochondrial delivery

    LHON (eye)

    Current public stageProof of concept
  5. MGS-MT-002Mitochondrial delivery

    AMI (heart)

    Current public stageProof of concept
  6. MGS-MT-003Mitochondrial delivery

    Anti-aging

    Current public stageProof of concept
  7. MGS-ON-001Complex drug-type delivery

    Oncology

    Current public stageProof of concept

IN VITRO DIAGNOSTIC REAGENTS

In vitro diagnostic reagents

5 PROGRAMS IN DEVELOPMENTPIPELINE OVERVIEW / R&D PROGRESS

Focused on early disease recognition and risk stratification, this track advances from kit development and registration testing to clinical application.

In vitro diagnostic reagent pipeline

ProgramsPROGRAMS
01Early proof of concept早期概念验证02Kit development试剂盒开发03Kit manufacturing and registration testing试剂盒生产及注册检验04Clinical trials and submission临床试验及申报05Approval and commercial launch取证与上市销售
  1. MD-001Disseminated intravascular coagulation (DIC)
  2. MD-002Acute myocardial infarction and heart failure
  3. MD-003Brain injury
  4. MD-004Autoimmune diseases
  5. MD-005Early cancer screening
  1. MD-001

    Disseminated intravascular coagulation (DIC)

    Current public stageClinical trials and submission
  2. MD-002

    Acute myocardial infarction and heart failure

    Current public stageKit development
  3. MD-003

    Brain injury

    Current public stageKit development
  4. MD-004

    Autoimmune diseases

    Current public stageKit development
  5. MD-005

    Early cancer screening

    Current public stageEarly proof of concept

Partner with us on migrasome research and clinical translation.

We welcome research partners to explore migrasome approaches to disease, drawing on our established capabilities in delivery, diagnostic reagents, and related platforms.

Contact us